Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Anavex Life Sciences Corp. (AVXL) had Weighted-Average Shares Outstanding (Diluted) of 92.90M for the most recently reported fiscal quarter, ending 2026-06-30.
| Income Statement Financials | |
-- |
|
$7.82M |
|
-- |
|
-- |
|
$-6.74M |
|
$6.74M |
|
$1.09M |
|
$7.82M |
|
$7.82M |
|
$7.82M |
|
$7.82M |
|
$7.82M |
|
$7.82M |
|
$6.74M |
|
$6.74M |
|
92.70M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
92.90M |
$0.08 |
|
$0.08 |
|
| Balance Sheet Financials | |
$120.14M |
|
-- |
|
-- |
|
$120.14M |
|
$7.69M |
|
-- |
|
-- |
|
$7.69M |
|
$112.45M |
|
$112.45M |
|
$112.45M |
|
92.70M |
|
| Cash Flow Statement Financials | |
$-20.69M |
|
-- |
|
$36.44M |
|
$102.58M |
|
$118.33M |
|
$15.75M |
|
$-15.66M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
15.62 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-20.69M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
6.96% |
|
6.96% |
|
6.51% |
|
6.96% |
|
$1.21 |
|
$-0.22 |
|
$-0.22 |
|